Clinical Trial Update: A Research Study on How NNC0487-0111, a New Medicine, Works in Chinese Participants After 10 Days of Oral Dosing [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating NNC0487-0111 in Chinese participants with overweight/obesity completed after 10 days of oral dosing. The study was sponsored by Novo …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Overweight

Drugs mentioned

• NNC0487-0111

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Overweight, Obesity | Phase 1 | Status: COMPLETED